Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT01176578 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Exercise Endothelial Progenitor Cells (EPCs) and Type 2 Diabetes

Study acronym: EPC-DM
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study completion date: Dec 31, 2025 to Dec 31, 2026v15
  2. Study completion date: Dec 31, 2024 to Dec 31, 2025v14
  3. Study completion date: Dec 31, 2022 to Dec 31, 2024v13
  4. Collaborator revisedv12
  5. Primary completion date: Sep 2021 to Dec 31, 2021
    • Study completion date: Sep 2021 to Dec 31, 2022
    v11
Show 9 earlier versionsHide 9 earlier versions
  1. Primary completion date: Sep 2019 to Sep 2021
    • Collaborator revised
    v10
  2. Primary completion date: Sep 2018 to Sep 2019
    • Trial status: Recruiting to Active, Not Recruiting
    • Study completion date: Sep 2021
    • Site details revised
    v9
  3. Re-verified, no change to tracked fieldsv8
  4. Primary completion date: Sep 2017 to Sep 2018v7
  5. 2 versions Re-verified since Jan 12, 2016, no change to tracked fieldsv5-v6
  6. Primary completion date: Sep 2013 to Sep 2017
    • Site contact updated
    v4
  7. Re-verified, no change to tracked fieldsv3
  8. Trial status: Not Yet Recruiting to Recruiting
    • Primary completion date: Sep 2012 to Sep 2013
    • Start date: Sep 2010 to Jul 2011
    • Site details revised
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The discovery of the role of endothelial progenitor cells (EPCs) and their involvement in the cardiovascular complications of type 2 diabetes (T2DM) would quickly have a significant impact on the millions of Americans who have T2DM. This project is designed to 1) determine the mechanisms underlying EPC dysfunction in older, sedentary adults with T2DM compared those with normal glucose metabolism and impaired glucose metabolism, and 2) determine if aerobic exercise training is an efficacious therapy for EPC dysfunction in T2DM, and whether improvement in EPC number and function translates to improved endothelial function, increased capillarization, and improved glucose metabolism in T2DM.
Trial Details
NCT Number NCT01176578
Lead Sponsor Baltimore VA Medical Center
Collaborators: University of Maryland, Baltimore
Conditions
(from sponsor)		 Type 2 Diabetes Mellitus
Related terms Diabetes Mellitus, Type 2
Enrollment 70 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov